Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study

Authors: Ki-Hyun Baek, Yoon-Sok Chung, Jung-Min Koh, In Joo Kim, Kyoung Min Kim, Yong-Ki Min, Ki Deok Park, Rajani Dinavahi, Judy Maddox, Wenjing Yang, Sooa Kim, Sang Jin Lee, Hyungjin Cho, Sung-Kil Lim

Source: Endocrinology and Metabolism, Vol 36, Iss 1, Pp 60-69 (2021)

Subject Terms: bone density, bone turnover markers, korea, randomized controlled trial, romosozumab, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

File Description: electronic resource

Relation: http://www.e-enm.org/upload/pdf/enm-2020-848.pdf; https://doaj.org/toc/2093-596X; https://doaj.org/toc/2093-5978

Access URL: https://doaj.org/article/3489359b9d0d468fb2715a4df5dbd747